Demonstrated in vivo effect

Follow

Industry

CPC
C12N2760/12171

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C12Biochemistry C12NMICRO-ORGANISMS OR ENZYMES COMPOSITIONS THEREOF PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS MUTATION OR GENETIC ENGINEERING CULTURE MEDIA C12N2760/00ssRNA Viruses negative-sense

Current Industry

C12N2760/12171Demonstrated in vivo effect

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Sin Nombre virus full-length M segment-based DNA vaccines
- Patent number 11,155,834
- Issue date Oct 26, 2021
- The Government of the United States, as represented by the Secretary of the Army
- Jay Hooper
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Gene optimized Hantaan virus M segment DNA vaccine for hemorrhagic...
- Patent number 10,493,142
- Issue date Dec 3, 2019
- Connie Schmaljohn
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Gene optimized hantaan virus M segment DNA vaccine for hemorrhagic...
- Patent number 9,968,669
- Issue date May 15, 2018
- The United States of America, as represented by the Secretary of the Army
- Connie Schmaljohn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Gene Optimized Hantaan Virus M Segment DNA Vaccine For Hemorrhagic...
- Publication number 20180280495
- Publication date Oct 4, 2018
- Government of the United States, as represented by the Secretary of the Army
- Connie Schmaljohn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE